Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Choe

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Haematologica|September 11, 2025
Early cytokine and chemokine signals shape the anti-AML activity of bispecific engager-secreting T cellsNatalie J Holl, Adam Fearnow, Ilias Christodoulou, et al.
Scientific Reports|October 17, 2022
Discovery of small molecule inhibitors that effectively disrupt IQGAP1-Cdc42 interaction in breast cancer cellsSamar Sayedyahossein, Jessica Smith, Elena Barnaeva, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
B7-H3-targeted natural killer cells effectively kill atypical teratoid / rhabdoid tumors and extend survival in orthotopic xenograftsJun Choe, Sachiv Chakravarti, Natalie J Holl, et al.
ACS Pharmacology & Translational Science|October 5, 2021
Hybrid <i>In Silico</i> Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 VariantsSankalp Jain, Daniel C Talley, Bolormaa Baljinnyam, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agentsJoshua E Hochuli, Sankalp Jain, Cleber Melo-Filho, et al.
ACS Pharmacology & Translational Science|July 13, 2022
Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 AgentsJoshua E Hochuli, Sankalp Jain, Cleber Melo-Filho, et al.
Cancer Research Communications|August 26, 2024
Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R DomainStamatia C Vorri, Natalie J Holl, Michael Leeming, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionalityRuyan Rahnama, Monika Kizerwetter, Huilin Yang, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Haematologica|September 11, 2025
Early cytokine and chemokine signals shape the anti-AML activity of bispecific engager-secreting T cellsNatalie J Holl, Adam Fearnow, Ilias Christodoulou, et al.
Scientific Reports|October 17, 2022
Discovery of small molecule inhibitors that effectively disrupt IQGAP1-Cdc42 interaction in breast cancer cellsSamar Sayedyahossein, Jessica Smith, Elena Barnaeva, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
B7-H3-targeted natural killer cells effectively kill atypical teratoid / rhabdoid tumors and extend survival in orthotopic xenograftsJun Choe, Sachiv Chakravarti, Natalie J Holl, et al.
ACS Pharmacology & Translational Science|October 5, 2021
Hybrid <i>In Silico</i> Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 VariantsSankalp Jain, Daniel C Talley, Bolormaa Baljinnyam, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agentsJoshua E Hochuli, Sankalp Jain, Cleber Melo-Filho, et al.
ACS Pharmacology & Translational Science|July 13, 2022
Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 AgentsJoshua E Hochuli, Sankalp Jain, Cleber Melo-Filho, et al.
Cancer Research Communications|August 26, 2024
Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R DomainStamatia C Vorri, Natalie J Holl, Michael Leeming, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionalityRuyan Rahnama, Monika Kizerwetter, Huilin Yang, et al.
Pageof 3